Picture of Clearpoint Neuro logo

CLPT Clearpoint Neuro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Clearpoint Neuro Inc expected to post a loss of 14  cents a share - Earnings Preview

* Clearpoint Neuro Inc  CLPT.OQ   CLPT.O  is expected to show a
rise in quarterly revenue when it reports results on May 11 .
* The Irvine, California-based company is expected to report   a
5.1% increase in revenue to $3.274 million from $3.12 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Clearpoint Neuro Inc is
for a loss of 14 cents per share. For the same quarter last
year, the company reported a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had fallen by
about 62.5% in the last three months. ​
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $35​, about 45.9% above​ its last closing price
of $18.94. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.13       -0.13      -0.09     Beat    30.8
 Sep. 30 2020  -0.14       -0.14      -0.09     Beat    35.7
 Jun. 30 2020  -0.16       -0.16      -0.11     Beat    31.3​
 Mar. 31 2020  -0.18       -0.18      -0.13     Beat    27.8
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated May 8 at 00:50 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Clearpoint Neuro

See all news